Lindsey James, PhD, is one of five early career faculty to win a 2025 Hettleman Prize, which recognizes groundbreaking, innovative research and future career promise.
James is a member of the HIV Cure Center through the Institute for Global Health and Infectious Diseases, assistant professor with the UNC Eshelman School of Pharmacy, (James Lab), and an assistant professor of chemical biology and medicinal chemistry
Her research focuses on understanding and controlling gene expression. She designs special molecules that can either block the activity of or break down the proteins responsible for controlling gene activity. One of her major achievements is creating new tools that can target and eliminate harmful proteins that were previously considered “undruggable.” These proteins are often involved in cancer, and by removing them, James’ work opens the door to new kinds of treatments.